Phase II study of mitomycin C plus 5-fluorouracil in patients with refractory ovarian cancer

Eur J Cancer. 1994;30A(8):1206-7. doi: 10.1016/0959-8049(94)90490-1.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II
  • Letter

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Female
  • Fluorouracil / administration & dosage*
  • Fluorouracil / adverse effects
  • Humans
  • Middle Aged
  • Mitomycin / administration & dosage*
  • Mitomycin / adverse effects
  • Ovarian Neoplasms / drug therapy*

Substances

  • Mitomycin
  • Fluorouracil